Company profile: Syngenta
1.1 - Company Overview
Company description
- Provider of agricultural technologies and solutions that improve yields, crop resilience, and resource conservation. Offers crop protection from sowing to harvest; seeds and traits for grains, oilseeds, vegetables, fruits, and flowers; TYMIRIUM technology against nematodes and soil-borne pathogens; PERGADO Ultra fungicide for cocoa; and Shoots by Syngenta, a collaborative platform advancing sustainable agriculture.
Products and services
- Seeds: Syngenta architects custom-engineered seeds and traits for grains, oilseeds, vegetables, fruits, and flowers, innovating to enhance yields, resilience in harsher climates, and conservation of limited resources
- Crop Protection: Syngenta delivers industrial-grade crop protection systems spanning sowing to harvesting, countering pests and diseases to ensure plant health and support reliable yields across diverse growing conditions
- TYMIRIUM Technology: Syngenta produces modular TYMIRIUM technology protecting against plant-parasitic nematodes and soil-borne pathogens, with applications as in-field treatments or seed-applied protection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Syngenta
PreventionGenetics
HQ: United States
Website
- Description: Provider of comprehensive genetic testing services, including whole-genome (PGnome) and whole-exome (PGxome) sequencing; targeted panels across endocrinology, hematology, and immunology; and Sanger sequencing, aCGH, and MLPA to detect and confirm genetic variants, deletions, and duplications across nearly all clinically relevant genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreventionGenetics company profile →
Cartana
HQ: Sweden
Website
- Description: Provider of in situ sequencing (ISS) technology to map gene expression in brain tissue, enabling simultaneous analysis of hundreds of genes across all cells in a tissue while preserving tissue morphology, with high sensitivity and throughput.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cartana company profile →
Resolution Bioscience
HQ: United States
Website
- Description: Provider of next-generation liquid biopsy cancer diagnostics using NGS to interrogate cell-free DNA from blood. Offerings include the ctDx Platform; ctDx FIRST, an FDA-approved NGS assay for comprehensive genomic profiling of 109 genes and detection of KRAS G12C in NSCLC; ctDx Lung for real-time NSCLC genotype assessment; custom liquid-biopsy panels for clinical trials and companion diagnostics; and TCR profiling for immuno-oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resolution Bioscience company profile →
Toma Biosciences
HQ: United States
Website
- Description: Provider of DNA-based cancer testing technology, developed and provided by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Toma Biosciences company profile →
Seek Labs
HQ: United States
Website
- Description: Provider of CRISPR-based technology targeting cellular replication to eliminate a cell or pathogen’s ability to replicate, CRISPR-based pharmaceuticals, point-of-care molecular diagnostic tools, laboratory-quality molecular diagnostic testing at the point of care, genetic material purification, and a secure digital platform to communicate easy-to-understand diagnostic results and track health trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seek Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Syngenta
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Syngenta
2.2 - Growth funds investing in similar companies to Syngenta
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Syngenta
4.2 - Public trading comparable groups for Syngenta
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →